MoneyWorks4Me

Biocon informs about credit rating

18 Jun 2025 Evaluate
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that CRISIL Ratings (‘CRISIL’) has reaffirmed the credit ratings on the bank facilities of the Company. The company has enclosed the rating action by CRISIL. A copy of the rating rationale issued by CRISIL is also enclosed. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..